Projects per year
Fingerprint
Dive into the research topics where Marina Konopleva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Finished
-
Administrative Core
Konopleva, M., Konopleva, M. M. Y. & Kantarjian, H.
9/1/18 → 8/31/23
Project: Research project
-
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia
Short, N. J., Jabbour, E., Jain, N., Senapati, J., Nasr, L., Haddad, F. G., Li, Z., Hsiao, Y. C., Yang, J. J., Pemmaraju, N., Ohanian, M., Wierda, W. G., Montalban-Bravo, G., Borthakur, G., Han, L., Xiao, L., Huang, X., Abramova, R., Zhao, M., Garris, R., & 3 others , Feb 27 2024, In: Blood Advances. 8, 4, p. 909-915 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro
Hurrish, K. H., Su, Y., Patel, S., Ramage, C. L., Zhao, J., Temby, B. R., Carter, J. L., Edwards, H., Buck, S. A., Wiley, S. E., Hüttemann, M., Polin, L., Kushner, J., Dzinic, S. H., White, K., Bao, X., Li, J., Yang, J., Boerner, J., Hou, Z., & 9 others , Feb 2024, In: Biochemical Pharmacology. 220, 115981.Research output: Contribution to journal › Article › peer-review
-
Erratum: Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia (2023) 37 10 (2006-2016))
Tian, Z., Shi, C., Yang, G., Allen, J. K., Shi, Q., Al-Shami, A., Olson, J. W., Smith, M. G., Chang, Q., Kaur, J., You, J., Lofton, T. E., Gonzalez, M. A., Zhang, Q., Zha, D. X., Tasian, S. K., Jain, N., Konopleva, M. Y., Heffernan, T. & Molldrem, J. J., Jan 1 2024, In: Leukemia. 38, 1, p. 226 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Feasible diet and circadian interventions reduce in vivo progression of FLT3-ITD-positive acute myeloid leukemia
Rodriguez, M., Fekry, B., Murphy, B., Figueroa, M., Cheng, T., Raber, M., Wartenberg, L., Bell, D., Triche, L., Crawford, K., Ma, H., Allton, K., Ahmed, R., Tran, J., Ranieri, C., Konopleva, M., Barton, M., Nunez, C., Eckel-Mahan, K. & Chandra, J., Jan 2024, In: Cancer Medicine. 13, 2, e6949.Research output: Contribution to journal › Article › peer-review
Open Access -
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort
Hammami, M. B., Verceles, J. A., Goldfinger, M., Shah, N. N., Sica, R. A., Mantzaris, I., Kornblum, N., Konopleva, M., Shastri, A., Shapiro, L. C., Feldman, E. J., Gritsman, K., Verma, A. & Cooper, D. L., 2024, (Accepted/In press) In: Transplantation and Cellular Therapy.Research output: Contribution to journal › Article › peer-review